𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The Use of Bone Markers in a 6-Week Study to Assess the Efficacy of Oral Clodronate in Patients with Metastatic Bone Disease

✍ Scribed by J. E. Brown; E. V. McCloskey; J. A. Dewar; J. J. Body; D. A. Cameron; A. N. Harnett; M. Ruutu; O. P. Purohit; R. Tähtelä; R. E. Coleman

Publisher
Springer
Year
2007
Tongue
English
Weight
308 KB
Volume
81
Category
Article
ISSN
1432-0827

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The clinical use of bone resorption mark
The clinical use of bone resorption markers in patients with malignant bone disease
✍ Robert E. Coleman 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 278 KB 👁 1 views

## Abstract ## BACKGROUND Advanced tumors often metastasize to bone, resulting in a variety of skeletal complications. Bisphosphonates are potent inhibitors of osteoclast‐mediated bone resorption that reduce the incidence and delay the onset of skeletal complications and reduce the need for radiat

Inability of bone turnover marker as a s
Inability of bone turnover marker as a strong prognostic indicator in prostate cancer patients with bone metastasis: Comparison with the extent of disease (EOD) grade
✍ Akimoto, Susumu; Furuya, Yuzo; Akakura, Koichiro; Shimazaki, Jun; Ito, Haruo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 2 views

## Background: Although clinical investigations of bone turnover markers in prostate cancer patients have been conducted, the relationships of pretreatment levels of the markers to the prognosis of patients with bone metastasis has not been fully examined. ## Methods: The serum levels of carboxy-